Clinical analyses of immunological and metabolic factors in ME/CFS - the MIRACLE study

Clinical analyses of immunological and metabolic factors in ME/CFS - the MIRACLE study - MIRACLE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035953

Enrollment

400

Registered

2025-01-31

Start date

2025-02-27

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myalgic Encephalitis / Chronic Fatigue Syndrome G93.3

Interventions

Group 1: 200 persons suffering from ME/CFS are included and data on symptoms, previous therapy, a laboratory panel and examinations (hand strength measurement, standing test, capillary microscopy, HDL

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Fulfillment of the diagnostic criteria for ME/CFS (collected via online questionnaire and, in case of doubt, additionally via online consultation)

Exclusion criteria

Exclusion criteria: Pregnancy No consent Age < 18

Design outcomes

Primary

Measure	Time frame
Epidemiological data on the prevalence and symptoms of ME/CFS Identification of subgroups/clusters of ME/CFS	—

Secondary

Measure	Time frame
Risk factors for ME/CFS Biomarkers for ME/CFS (a.o. PMN function, surface antigens)	—

Countries

Germany

Contacts

Public ContactElisabeth Schieffer

Universitätsklinikum Gießen-Marburg, Standort Marburg

miracle.mr@uk-gm.de+49 6421 58-74886

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026